Journal of Medicinal Chemistry p. 6247 - 6260 (2018)
Update date:2022-08-15
Topics:
Vandyck, Koen
Rombouts, Geert
Stoops, Bart
Tahri, Abdellah
Vos, Ann
Verschueren, Wim
Wu, Yiming
Yang, Jingmei
Hou, Fuliang
Huang, Bing
Vergauwen, Karen
Dehertogh, Pascale
Berke, Jan Martin
Raboisson, Pierre
Small molecule induced hepatitis B virus (HBV) capsid assembly modulation is considered an attractive approach for new antiviral therapies against HBV. Here we describe efforts toward the discovery of a HBV capsid assembly modulator in a hit-to-lead optimization, resulting in JNJ-632, a tool compound used to further profile the mode of action. Administration of JNJ-632 (54) in HBV genotype D infected chimeric mice resulted in a 2.77 log reduction of the HBV DNA viral load.
View MoreShanghai Sunway Pharmaceutical Technology Co.,Ltd.
Contact:+86-21-5161 3915
Address:Shanghai YangPu
shijiazhuang baisheng chem co.; ltd
Contact:86-0311-80790826
Address:shijiazhuang hebei
Suzhou Lixin Pharmaceutical Co., Ltd.
Contact:86-512-88169812
Address:21 Tangxi Road, Suzhou New District, Suzhou 215151
Chemvon Biotechnology Co. Ltd.
website:http://www.chemvon.com
Contact:86-21-58550039;86-21-31268550-8004
Address:Suite B-10#, 6999 Chuansha Road, Pudong District, Shanghai 201202, China
Contact:0086-29-89196322
Address:North of the Fifth Keji Road, Hi-Tech Industrial Zone, Xi'an City, Shaanxi Province, China
Doi:10.1021/jacs.5b01784
(2015)Doi:10.1016/S0040-4039(00)73065-6
(1994)Doi:10.1080/07328300008544075
(2000)Doi:10.1039/c3gc41898g
(2014)Doi:10.1016/S0040-4039(00)76990-5
(1994)Doi:10.1248/cpb.48.238
(2000)